<p>需求加速推动强劲的收入增长</p>
<p>加拿大不列颠哥伦比亚省温哥华 --（Newsfile Corp. -2025 年 12 月 15 日）- Burcon NutraScience Corporation（OTCQB: BRCNF）（&#34; <strong>Burcon</strong>&#34;或&#34; <strong>公司</strong>&#34;），作为植物基蛋白创新的全球技术领导者，欣然向股东发布首席执行官 Kip Underwood 的信件。</p>
<p>亲爱的股东们，</p>
<p>2025 年对 Burcon 来说是一个变革之年，标志着我们在 2026 年进入一个激动人心的增长阶段的开始。我可以自信地说，Burcon 现在的地位比以往任何时候都要强大。我们在商业执行、制造和技术验证方面的成就，使我们在推进商业化旅程的下一个阶段时，具备了有意义的增长潜力。</p>
<p><strong>商业势头与销售增长</strong></p>
<p>在最近几个月，我们看到客户从评估阶段进展到商业采购订单，这得益于我们清晰的产品差异化——高纯度、清爽的口感以及在多种食品和饮料应用中的功能性。</p>
<p>目前，我们在豌豆、菜籽和蚕豆蛋白平台上产生了成分销售，预计 2025 年的收入将在 100 万到 300 万美元之间。近期客户活动和不断扩大的采购承诺反映出强劲的市场接受度，并转化为不断增长的收入。在此基础上，我们重申 2026 年收入超过 1000 万美元的目标。</p>
<p><strong>经过验证的蛋白技术平台</strong></p>
<p>通过与 RE ProMan LLC 的战略制造合作伙伴关系，我们继续推进 Burcon 蛋白技术平台的商业部署，实现可扩展、可靠的生产，以满足多个蛋白类别日益增长的客户需求。</p>
<p>今年的一项重大成就是我们在全商业规模上成功验证了我们的专利蛋白技术。这一成就显著降低了技术和执行风险，并确认了 Burcon 能够持续提供高性能蛋白成分，进入快速扩展的食品和营养市场。</p>
<p><strong>行业需求与 Burcon 的优势相一致</strong></p>
<p>食品和饮料制造商越来越寻求清洁标签、口感更佳的植物蛋白。Burcon 的成分提供高纯度和高性能，使制造商能够提供消费者喜爱的高质量产品。</p>
<p>市场需求与我们核心优势的这种一致性，推动了 200 多个新客户项目的管道，并推动了从评估到商业成分销售的进展。</p>
<p><strong>财务准备</strong></p>
<p>Burcon 正处于一个转折点。为了充分利用这一势头，我们正在进行有针对性的生产投资，以满足不断上升的需求并支持加速增长。Burcon 正在完成一项融资，预计其收益将：</p>
<ul>
<li>支持客户入驻并加速成分销售的转化</li>
<li>随着需求的扩大，增加运营产出</li>
<li>在我们的商业扩展期间增强资产负债表的灵活性</li>
</ul>
<p>该融资得到了内部人士和我们的制造合作伙伴的强力支持，反映出对我们运营和战略的信心。一旦完成，融资预计将增强我们的资产负债表，以加速近期的增长计划并实现正现金流。</p>
<p>这项融资的关键目标是在 Burcon 获得商业牵引力和收入可见性的时刻，加速我们的执行。</p>
<p><strong>以强劲势头迎接 2026 年</strong></p>
<p>Burcon 以坚实的基础进入 2026 年：经过验证的技术、可扩展的商业设施、不断增长的成分销售和日益增强的客户需求。此外，我们对收入目标有清晰的视野，并对实现正现金流的路径充满信心。</p>
<p>最后，我们预计 2026 年将是 Burcon 的重大增长之年，也是我们为您——我们的股东，带来有意义价值的一年。感谢您对我们使命的持续支持和信任。</p>
<p>诚挚的，</p>
<p>&#34;Kip Underwood&#34;</p>
<p>Kip Underwood</p>
<p>首席执行官</p>
<p><strong>关于 Burcon NutraScience Corporation</strong></p>
<p>Burcon 是食品和饮料行业高性能植物基蛋白的全球技术领导者。我们的商业成分提供卓越的口感、质地和功能性，理想适合寻求下一代蛋白解决方案的配方师。凭借超过二十年的创新，Burcon 拥有广泛的专利组合，涵盖从豌豆、菜籽、大豆、麻、向日葵及其他植物来源提取的新型蛋白。作为快速增长的植物基市场的关键参与者，Burcon 致力于可持续发展，并创造对人类和地球更好的一流蛋白解决方案。了解更多信息，请访问 www.burcon.ca。</p>
<p><strong>前瞻性信息警示声明</strong></p>
<p>多伦多证券交易所未对本信息内容的充分性进行审查，也不承担任何责任。本新闻稿包含根据 1995 年美国私人证券诉讼改革法案及适用的加拿大证券立法的定义的前瞻性陈述或前瞻性信息，包括与内部人参与私募相关的陈述。前瞻性陈述或前瞻性信息涉及风险、不确定性和其他因素，这些因素可能导致实际结果、表现、前景和机会与此类前瞻性陈述所表达或暗示的结果存在重大差异。前瞻性陈述或前瞻性信息可以通过诸如 “预期”、“目标”、“打算”、“计划”、“目标”、“项目”、“估计”、“期望”、“相信”、“未来”、“可能”、“应当”、“能够”、“将会” 等类似词语来识别，均指向未来的时间段。本发布中包含的所有陈述，除了历史事实的陈述外，均为前瞻性陈述。不能保证这些陈述将被证明是准确的，实际结果和未来事件可能与这些陈述或信息中预期的结果存在重大差异。可能导致实际结果与 Burcon 的计划和预期存在重大差异的重要因素包括我们商业模式和增长战略的实施；我们行业的趋势和竞争；我们未来的业务发展、财务状况和运营结果；以及我们以成本效益的方式获得融资的能力；政府法规的潜在变化，以及本文件中详细列出的其他风险和因素，以及 Burcon 不时向证券监管机构和证券交易所提交的文件，包括在 Burcon 截至 2025 年 3 月 31 日的年度信息表中的 “风险因素” 部分，以及其在 SEDAR+ 上向加拿大证券监管机构提交的其他公开文件，网址为 www.sedarplus.ca。此列表并非影响公司任何前瞻性陈述或信息的因素的详尽清单。任何前瞻性陈述或信息仅在其作出之日有效，除非适用的证券法要求，Burcon 不承担更新任何前瞻性陈述的意图或义务，无论是由于新信息、未来事件还是其他原因。尽管 Burcon 相信前瞻性陈述中固有的假设是合理的，但前瞻性陈述并不保证未来的表现，因此，投资者不应依赖这些陈述。</p>
<p><strong>行业和投资者联系</strong></p>
<p>Paul Lam</p>
<p>投资者关系与传播总监</p>
<p>Burcon NutraScience Corporation</p>
<p>490 - 999 West Broadway, Vancouver, BC, V5Z 1K5</p>
<p>电话 (604) 733-0896，免费电话 (888) 408-7960</p>
<p>plam@burcon.ca www.burcon.ca</p>
<p><strong>媒体联系：</strong></p>
<p>Steve Campbell, APR</p>
<p>总裁</p>
<p>Campbell &amp; Company Public Relations</p>
<p>电话 (604) 888-5267</p>
<p>TECH@CCOM-PR.COM</p>
<p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/278025</p>

BRCNF

BRCND

<p>Burcon NutraScience Corporation 发布了一封股东信，强调了 2025 年强劲的执行力和商业势头。公司报告称，由于对其植物基蛋白产品的高需求，收入实现了显著增长。Burcon 预计 2025 年的收入将在 100 万到 300 万美元之间，并计划在 2026 年超过 1000 万美元。公司已在商业规模上验证了其蛋白技术，并正在进行有针对性的生产投资以满足不断增长的需求。Burcon 正在敲定融资以支持增长，并计划在 2026 年实现正现金流</p>

<p>Accelerating Demand Driving Strong Revenue Growth</p>
<div class="lb-trans"><p>需求加速推动强劲的收入增长</p>
</div><p>Vancouver, British Columbia--(Newsfile Corp. - December 15, 2025) - Burcon NutraScience Corporation  (OTCQB: BRCNF) (&#34; <strong>Burcon</strong>&#34; or the &#34; <strong>Company</strong>&#34;), a global technology leader in plant-based protein innovation, is pleased to issue a letter to shareholders from its Chief Executive Officer, Kip Underwood.</p>
<div class="lb-trans"><p>加拿大不列颠哥伦比亚省温哥华 --（Newsfile Corp. -2025 年 12 月 15 日）- Burcon NutraScience Corporation（OTCQB: BRCNF）（&#34; <strong>Burcon</strong>&#34;或&#34; <strong>公司</strong>&#34;），作为植物基蛋白创新的全球技术领导者，欣然向股东发布首席执行官 Kip Underwood 的信件。</p>
</div><p>Dear Fellow Shareholders,</p>
<div class="lb-trans"><p>亲爱的股东们，</p>
</div><p>2025 was a transformational year for Burcon, marking the beginning of an exciting phase of growth as we build on our commercial momentum heading into 2026. I can say with confidence that Burcon has never been in a stronger position than it is today. Our achievements in commercial execution, manufacturing, and technology validation have positioned us for meaningful growth as we advance into the next phase of our commercialization journey.</p>
<div class="lb-trans"><p>2025 年对 Burcon 来说是一个变革之年，标志着我们在 2026 年进入一个激动人心的增长阶段的开始。我可以自信地说，Burcon 现在的地位比以往任何时候都要强大。我们在商业执行、制造和技术验证方面的成就，使我们在推进商业化旅程的下一个阶段时，具备了有意义的增长潜力。</p>
</div><p><strong>Commercial Momentum and Sales Growth</strong></p>
<div class="lb-trans"><p><strong>商业势头与销售增长</strong></p>
</div><p>In recent months, we have seen customers progress from evaluation to commercial purchase orders, driven by our clear product differentiation-high purity, clean taste, and functionality across multiple food and beverage applications.</p>
<div class="lb-trans"><p>在最近几个月，我们看到客户从评估阶段进展到商业采购订单，这得益于我们清晰的产品差异化——高纯度、清爽的口感以及在多种食品和饮料应用中的功能性。</p>
</div><p>Today, we are generating ingredient sales across our pea, canola, and fava protein platforms, with calendar 2025 revenue expected to be in the range of $1-3 million. Recent customer activity and expanding purchase commitments reflect strong market adoption and are translating into increasing revenue. Building on this momentum, we reaffirm our revenue target of more than $10 million for calendar 2026.</p>
<div class="lb-trans"><p>目前，我们在豌豆、菜籽和蚕豆蛋白平台上产生了成分销售，预计 2025 年的收入将在 100 万到 300 万美元之间。近期客户活动和不断扩大的采购承诺反映出强劲的市场接受度，并转化为不断增长的收入。在此基础上，我们重申 2026 年收入超过 1000 万美元的目标。</p>
</div><p><strong>Proven Protein Technology Platform</strong></p>
<div class="lb-trans"><p><strong>经过验证的蛋白技术平台</strong></p>
</div><p>Through our strategic manufacturing partnership with RE ProMan LLC, we continue to advance the commercial deployment of Burcon's protein technology platform, enabling scalable, reliable production to meet growing customer demand across multiple protein categories.</p>
<div class="lb-trans"><p>通过与 RE ProMan LLC 的战略制造合作伙伴关系，我们继续推进 Burcon 蛋白技术平台的商业部署，实现可扩展、可靠的生产，以满足多个蛋白类别日益增长的客户需求。</p>
</div><p>A major achievement this year was the successful validation of our patented protein technologies at full commercial scale. This accomplishment significantly reduces technology and execution risk and confirms Burcon's ability to consistently deliver high-performance protein ingredients into large and rapidly expanding food and nutrition markets.</p>
<div class="lb-trans"><p>今年的一项重大成就是我们在全商业规模上成功验证了我们的专利蛋白技术。这一成就显著降低了技术和执行风险，并确认了 Burcon 能够持续提供高性能蛋白成分，进入快速扩展的食品和营养市场。</p>
</div><p><strong>Industry Demand Aligned with Burcon's Strengths</strong></p>
<div class="lb-trans"><p><strong>行业需求与 Burcon 的优势相一致</strong></p>
</div><p>Food and beverage manufacturers are increasingly looking for clean-label, better-tasting plant proteins. Burcon's ingredients offer high purity and performance, enabling manufacturers to deliver high-quality products that consumers will enjoy.</p>
<div class="lb-trans"><p>食品和饮料制造商越来越寻求清洁标签、口感更佳的植物蛋白。Burcon 的成分提供高纯度和高性能，使制造商能够提供消费者喜爱的高质量产品。</p>
</div><p>This alignment of market demand with our core strengths is driving the pipeline of 200+ new customer projects and driving the progression from evaluations into commercial ingredient sales.</p>
<div class="lb-trans"><p>市场需求与我们核心优势的这种一致性，推动了 200 多个新客户项目的管道，并推动了从评估到商业成分销售的进展。</p>
</div><p><strong>Financial Readiness</strong></p>
<div class="lb-trans"><p><strong>财务准备</strong></p>
</div><p>Burcon is at an inflection point. To fully capitalize on this momentum, we are making targeted production investments to meet rising demand and support accelerated growth. Burcon is finalizing a financing, the proceeds of which are expected to:</p>
<div class="lb-trans"><p>Burcon 正处于一个转折点。为了充分利用这一势头，我们正在进行有针对性的生产投资，以满足不断上升的需求并支持加速增长。Burcon 正在完成一项融资，预计其收益将：</p>
</div><ul>
<li>Support customer onboarding and accelerate conversion of ingredient sales</li>
<li>Increase operational throughput as demand scales</li>
<li>Strengthen balance sheet flexibility during our commercial expansion</li>
</ul>
<div class="lb-trans"><ul>
<li>支持客户入驻并加速成分销售的转化</li>
<li>随着需求的扩大，增加运营产出</li>
<li>在我们的商业扩展期间增强资产负债表的灵活性</li>
</ul>
</div><p>The financing is strongly supported by insiders and by our manufacturing partner, reflecting confidence from those closest to our operations and strategy. Once completed, the financing is expected to strengthen our balance sheet to accelerate near-term growth initiatives and achieve positive cash flow.</p>
<div class="lb-trans"><p>该融资得到了内部人士和我们的制造合作伙伴的强力支持，反映出对我们运营和战略的信心。一旦完成，融资预计将增强我们的资产负债表，以加速近期的增长计划并实现正现金流。</p>
</div><p>The key objective of this financing is to accelerate our execution at a moment when Burcon is gaining commercial traction and revenue visibility.</p>
<div class="lb-trans"><p>这项融资的关键目标是在 Burcon 获得商业牵引力和收入可见性的时刻，加速我们的执行。</p>
</div><p><strong>Entering 2026 with Strong Momentum</strong></p>
<div class="lb-trans"><p><strong>以强劲势头迎接 2026 年</strong></p>
</div><p>Burcon enters 2026 with a strong foundation: proven technology, a scalable commercial facility, growing ingredient sales, and strengthening customer demand. Moreover, we have a clear line of sight to our revenue targets and confidence in our path toward achieving positive cash flow.</p>
<div class="lb-trans"><p>Burcon 以坚实的基础进入 2026 年：经过验证的技术、可扩展的商业设施、不断增长的成分销售和日益增强的客户需求。此外，我们对收入目标有清晰的视野，并对实现正现金流的路径充满信心。</p>
</div><p>In closing, we expect 2026 to be a year of substantial growth for Burcon, and one in which we deliver meaningful value back to you, our shareholders. Thank you for your continued support and belief in our mission.</p>
<div class="lb-trans"><p>最后，我们预计 2026 年将是 Burcon 的重大增长之年，也是我们为您——我们的股东，带来有意义价值的一年。感谢您对我们使命的持续支持和信任。</p>
</div><p>Sincerely,</p>
<div class="lb-trans"><p>诚挚的，</p>
</div><p>&#34;Kip Underwood&#34;</p>
<div class="lb-trans"><p>&#34;Kip Underwood&#34;</p>
</div><p>Kip Underwood</p>
<div class="lb-trans"><p>Kip Underwood</p>
</div><p>Chief Executive Officer</p>
<div class="lb-trans"><p>首席执行官</p>
</div><p><strong>About Burcon NutraScience Corporation</strong></p>
<div class="lb-trans"><p><strong>关于 Burcon NutraScience Corporation</strong></p>
</div><p>Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality-ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at www.burcon.ca.</p>
<div class="lb-trans"><p>Burcon 是食品和饮料行业高性能植物基蛋白的全球技术领导者。我们的商业成分提供卓越的口感、质地和功能性，理想适合寻求下一代蛋白解决方案的配方师。凭借超过二十年的创新，Burcon 拥有广泛的专利组合，涵盖从豌豆、菜籽、大豆、麻、向日葵及其他植物来源提取的新型蛋白。作为快速增长的植物基市场的关键参与者，Burcon 致力于可持续发展，并创造对人类和地球更好的一流蛋白解决方案。了解更多信息，请访问 www.burcon.ca。</p>
</div><p><strong>Forward-Looking Information Cautionary Statement</strong></p>
<div class="lb-trans"><p><strong>前瞻性信息警示声明</strong></p>
</div><p>The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, including statements relating to insider participation in the private placement. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as &#34;anticipate,&#34; &#34;aim&#34;, &#34;intend,&#34; &#34;plan,&#34; &#34;goal,&#34; &#34;project,&#34; &#34;estimate,&#34; &#34;expect,&#34; &#34;believe,&#34; &#34;future,&#34; &#34;likely,&#34; &#34;may,&#34; &#34;should,&#34; &#34;could,&#34; &#34;will&#34; and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled &#34;Risk Factors&#34; in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.</p>
<div class="lb-trans"><p>多伦多证券交易所未对本信息内容的充分性进行审查，也不承担任何责任。本新闻稿包含根据 1995 年美国私人证券诉讼改革法案及适用的加拿大证券立法的定义的前瞻性陈述或前瞻性信息，包括与内部人参与私募相关的陈述。前瞻性陈述或前瞻性信息涉及风险、不确定性和其他因素，这些因素可能导致实际结果、表现、前景和机会与此类前瞻性陈述所表达或暗示的结果存在重大差异。前瞻性陈述或前瞻性信息可以通过诸如 “预期”、“目标”、“打算”、“计划”、“目标”、“项目”、“估计”、“期望”、“相信”、“未来”、“可能”、“应当”、“能够”、“将会” 等类似词语来识别，均指向未来的时间段。本发布中包含的所有陈述，除了历史事实的陈述外，均为前瞻性陈述。不能保证这些陈述将被证明是准确的，实际结果和未来事件可能与这些陈述或信息中预期的结果存在重大差异。可能导致实际结果与 Burcon 的计划和预期存在重大差异的重要因素包括我们商业模式和增长战略的实施；我们行业的趋势和竞争；我们未来的业务发展、财务状况和运营结果；以及我们以成本效益的方式获得融资的能力；政府法规的潜在变化，以及本文件中详细列出的其他风险和因素，以及 Burcon 不时向证券监管机构和证券交易所提交的文件，包括在 Burcon 截至 2025 年 3 月 31 日的年度信息表中的 “风险因素” 部分，以及其在 SEDAR+ 上向加拿大证券监管机构提交的其他公开文件，网址为 www.sedarplus.ca。此列表并非影响公司任何前瞻性陈述或信息的因素的详尽清单。任何前瞻性陈述或信息仅在其作出之日有效，除非适用的证券法要求，Burcon 不承担更新任何前瞻性陈述的意图或义务，无论是由于新信息、未来事件还是其他原因。尽管 Burcon 相信前瞻性陈述中固有的假设是合理的，但前瞻性陈述并不保证未来的表现，因此，投资者不应依赖这些陈述。</p>
</div><p><strong>Industry and Investor Contact</strong></p>
<div class="lb-trans"><p><strong>行业和投资者联系</strong></p>
</div><p>Paul Lam</p>
<div class="lb-trans"><p>Paul Lam</p>
</div><p>Director, Investor Relations and Communications</p>
<div class="lb-trans"><p>投资者关系与传播总监</p>
</div><p>Burcon NutraScience Corporation</p>
<div class="lb-trans"><p>Burcon NutraScience Corporation</p>
</div><p>490 - 999 West Broadway, Vancouver, BC, V5Z 1K5</p>
<div class="lb-trans"><p>490 - 999 West Broadway, Vancouver, BC, V5Z 1K5</p>
</div><p>Tel (604) 733-0896, Toll-free (888) 408-7960</p>
<div class="lb-trans"><p>电话 (604) 733-0896，免费电话 (888) 408-7960</p>
</div><p>plam@burcon.ca www.burcon.ca</p>
<div class="lb-trans"><p>plam@burcon.ca www.burcon.ca</p>
</div><p><strong>Media Contact:</strong></p>
<div class="lb-trans"><p><strong>媒体联系：</strong></p>
</div><p>Steve Campbell, APR</p>
<div class="lb-trans"><p>Steve Campbell, APR</p>
</div><p>President</p>
<div class="lb-trans"><p>总裁</p>
</div><p>Campbell &amp; Company Public Relations</p>
<div class="lb-trans"><p>Campbell &amp; Company Public Relations</p>
</div><p>Tel (604) 888-5267</p>
<div class="lb-trans"><p>电话 (604) 888-5267</p>
</div><p>TECH@CCOM-PR.COM</p>
<div class="lb-trans"><p>TECH@CCOM-PR.COM</p>
</div><p>To view the source version of this press release, please visit https://www.newsfilecorp.com/release/278025</p>
<div class="lb-trans"><p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/278025</p>
</div>

Burcon 在股东信中强调了其强劲的执行表现和商业发展势头